EP4061370 - A PELLET COMPOSITION COMPRISING PROPIVERINE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 15.03.2024 Database last updated on 14.06.2024 | |
Former | Request for examination was made Status updated on 26.08.2022 | ||
Former | The international publication has been made Status updated on 29.05.2021 | Most recent event Tooltip | 11.06.2024 | Change: Despatch of examination report + time limit | Applicant(s) | For all designated states Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Istinye Mah. Balabandere Cad. No:14 34460 Sariyer/Istanbul / TR | [2022/39] | Inventor(s) | 01 /
SUNEL, Fatih Istinye Mahallesi Balabandere Caddesi No:14 34460 Sariyer/Istanbul / TR | 02 /
YILDIRIM, Ediz Istinye Mahallesi Balabandere Caddesi No:14 34460 Sariyer/Istanbul / TR | 03 /
TOK, Gulcin Istinye Mahallesi Balabandere Caddesi No:14 34460 Sariyer/Istanbul / TR | 04 /
DEMIR, Bulent Istinye Mahallesi Balabandere Caddesi No:14 34460 Sariyer/Istanbul / TR | [2022/39] | Representative(s) | Sevinç, Erkan Istanbul Patent A.S. Plaza-33, Büyükdere Cad. No: 33/16 Sisli 34381 Istanbul / TR | [2022/39] | Application number, filing date | 20889321.4 | 27.10.2020 | [2022/39] | WO2020TR50998 | Priority number, date | TR20190018013 | 19.11.2019 Original published format: TR 201918013 | [2022/39] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2021101481 | Date: | 27.05.2021 | Language: | EN | [2021/21] | Type: | A1 Application with search report | No.: | EP4061370 | Date: | 28.09.2022 | Language: | EN | The application published by WIPO in one of the EPO official languages on 27.05.2021 takes the place of the publication of the European patent application. | [2022/39] | Search report(s) | International search report - published on: | TR | 27.05.2021 | (Supplementary) European search report - dispatched on: | EP | 03.07.2023 | Classification | IPC: | A61K31/445, A61P13/00, A61P13/10, A61K47/38, A61K9/50, A61K9/16, A61K9/20, A61K9/22 | [2022/39] | CPC: |
A61K9/2077 (EP);
A61K31/445 (EP);
A61K9/1635 (EP);
A61P13/00 (EP);
A61P13/10 (EP);
A61K9/1652 (EP)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/39] | Title | German: | PELLETZUSAMMENSETZUNG MIT PROPIVERIN ODER EINEM PHARMAZEUTISCH AKZEPTABLEN SALZ DAVON | [2022/39] | English: | A PELLET COMPOSITION COMPRISING PROPIVERINE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | [2022/39] | French: | COMPOSITION DE GRANULÉS COMPRENANT DE LA PROPIVÉRINE OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELLE-CI | [2022/39] | Entry into regional phase | 17.05.2022 | National basic fee paid | 17.05.2022 | Search fee paid | 17.05.2022 | Designation fee(s) paid | 17.05.2022 | Examination fee paid | Examination procedure | 17.05.2022 | Examination requested [2022/39] | 17.01.2024 | Amendment by applicant (claims and/or description) | 17.01.2024 | Date on which the examining division has become responsible | 14.03.2024 | Despatch of a communication from the examining division (Time limit: M06) | Fees paid | Renewal fee | 25.10.2022 | Renewal fee patent year 03 | 26.10.2023 | Renewal fee patent year 04 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XI]US2009258066 (VENKATESH GOPI [US], et al) [X] 1-7 * paragraphs [0013] , [0 34] , [0 44] , [0 39]; examples 5,6,7; claims 15, 21, 28, 44 *[I] 1-11 | International search | [X]US2004258749 (GULDNER PETER [DE], et al) [X] 1-18 * Paragraphs 44, 55, 58, 60; examples 1-10. *; | [A]US2009117232 (BOLTRI LUIGI [IT], et al) [A] 1-18* Paragraph 16; claims 1-3,6; examples. *; | [X]CN102579404 (GUANGZHOU COREDES PHARMACEUTICAL TECHNOLOGY CO LTD) [X] 1-9 * Paragraphs 10-19, 25; example 3. * | by applicant | CN102579404 |